retatrutide triple agonist gip glp-1 glucagon receptor Agonism Based Therapies for Obesity Retatrutide Triple Agonist – Port

National Institute for Health and Care Research

GLP-3 Improves Steatohepatitis in an Accelerated Mouse Model of Diet-Induced Steatohepatitis with a Fructose Binge, Viebahn GK

In the efficacy-estimand analysis, participants taking the highest dose (12 mg) lost an average of 28.7% of their body weight at 68 weeks, about 71.2 pounds from a baseline of 248.5 pounds

If youre in Canada (or any country with free healthcare) and have any of the above conditions or are susceptible due to family genetics, then seeing your doctor is a good first step before considering Tirzepatide

Severe abdominal pain, particularly if it spreads to the back, may require medical assessment

Some experience increased heart rate and body warmth from the thermogenic glucagon receptor activation